Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel

It has been suggested that the benefit of adjuvant chemotherapy (CT) in premenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 negative (HER2−) early breast cancer may be related, at least in part, to CT-induced ovarian function suppression (OFS) in this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Arboleda, Bolivar, Bartsch, Rupert, de Azambuja, Evandro, Hamilton, Erika, Harbeck, Nadia, Klemp, Jennifer, Knauer, Michael, Kuemmel, Sherko, Mahtani, Reshma, Schwartzberg, Lee, Villarreal-Garza, Cynthia, Wolff, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438910/
https://www.ncbi.nlm.nih.gov/pubmed/35704278
http://dx.doi.org/10.1093/oncolo/oyac101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438910/
https://www.ncbi.nlm.nih.gov/pubmed/35704278
http://dx.doi.org/10.1093/oncolo/oyac101

Ejemplares similares